Neuropsychiatric Disorders in Parkinson’s Disease
Abstract
This article discusses neuropsychiatric disorders in Parkinson’s disease. We have demonstrated high efficiency in relation to fatigue in PD ADR Mirapex. So, if before therapy a pronounced degree of fatigue according to the corresponding scale for assessing fatigue was noted in 64% of patients, then after treatment - only in 26%. It is important that no significant correlation was found between the dynamics of indicators of fatigue and motor functions, depression, sleep disorders during therapy, which indirectly indicates independent genesis of this symptom and specificity the Mirapex effect.
Keywords
neuropsychic disorder, sensory disorder, autonomic disorder,, depression, dementia, patients, fatigue,, significant correlation, dynamics of indicators, independent genesisHow to Cite
References
Noe-Sebastian, E., Irimia-Sieira, P., Pomares-Arias, E., Martinez-Vila, E., & Luquin-Piudo, M. R. (2001). Neuropsychiatric disorders in Parkinson's disease. Revista de neurologia, 32(7), 676-681.
Dujardin, K., & Sgambato, V. (2020). Neuropsychiatric disorders in parkinson’s disease: what do we know about the role of dopaminergic and non-dopaminergic systems?. Frontiers in neuroscience, 14, 25.
Lang, A. E., & Lozano, A. M. (1998). Parkinson's disease. New England Journal of Medicine, 339(16), 1130-1143.
Dauer, W., & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39(6), 889-909.
De Lau, L. M., & Breteler, M. M. (2006). Epidemiology of Parkinson's disease. The Lancet Neurology, 5(6), 525-535.
Jankovic, J. (2008). Parkinson’s disease: clinical features and diagnosis. Journal of neurology, neurosurgery & psychiatry, 79(4), 368-376.
Cummings, J. L. (1992). Depression and Parkinson's disease: a review. The American journal of psychiatry.
Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer's disease and Parkinson's disease. New england journal of medicine, 348(14), 1356-1364.
Katzenschlager, R., Sampaio, C., Costa, J., & Lees, A. (2002). Anticholinergics for symptomatic management of Parkinson s disease. Cochrane Database of Systematic Reviews, (3).
Forno, L. S. (1988). The neuropathology of Parkinson’s disease. Progress in Parkinson Research, 11-21.
Calne, D. B., Snow, B. J., & Lee, C. (1992). Criteria for diagnosing Parkinson's disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 32(S1), S125-S127.
Davie, C. A. (2008). A review of Parkinson's disease. British medical bulletin, 86(1), 109-127.
License
Copyright (c) 2021 M.M.Raimova, S.A. Alikhanov
This work is licensed under a Creative Commons Attribution 4.0 International License.
The content published on the International Scientific and Current Research Conferences platform, including conference papers, abstracts, and presentations, is made available under an open-access model. Users are free to access, share, and distribute this content, provided that proper attribution is given to the original authors and the source.
